IP Library Granted Patent US 8,372,972
Granted Patent B2
US 8,372,972 · App. 13/308,418 · Granted Feb 12, 2013

Process for the preparation of dihydroquinazolines

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,372,972
App. No.
13/308,418
Granted
Feb 12, 2013
Kind
B2
Abstract

The present invention relates to a process for the preparation of dihydroquinazolines, for example, methyl (S)-{8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoro -methyl)-phenyl]-3,4-dihydroquinazolin-4-yl}acetate (2S,3S)-2,3-bis[(4-methylbenzoyl) -oxy]succinic acid salt, which are used for the production of antiviral medicaments.

Claims (2)

1. A process for isolating methyl (S)-{8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-3,4-dihydroquinazolin-4-yl}acetate (2S,3S)-2,3-bis[(4-methylbenzoyl)-oxy]succinic acid salt, comprising crystallizing racemic methyl -{8-fluoro -2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-3,4-dihydroquinazolin-4-yl}acetate with (2S,3S)-2,3-bis[(4-methylbenzoyl)oxy]succinic acid.

2. Methyl (S)-{8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy -5-(trifluoro-methyl)-phenyl]-3 ,4-dihydroquinazolin-4-yl}acetate (2S,3S)-2,3-bis[(4-methylbenzoyl)-oxy]succinic acid salt.

Assignments (3)
CHANGE OF NAME Recorded Sep 9, 2021
From: AIC246 GMBH & CO. KG
To: AIC246 AG & CO. KG
Reel/Frame 057447/0605 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 2, 2021
From: AICURIS ANTI-INFECTIVE CURES GMBH
To: AIC246 GMBH & CO. KG
Reel/Frame 057371/0159 →
CHANGE OF NAME Recorded Sep 26, 2018
From: AICURIS GMBH & CO. KG
To: AICURIS ANTI-INFECTIVE CURES GMBH
Reel/Frame 047152/0433 →